Jenburkt Pharmaceuticals Balance Sheet Annual

Trade

BSE: 524731 | NSE: - | ISIN: INE354A01013 | Sector: Biotechnology & Drugs

1,234.90 +72.55 (6.24%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	79.19	32.39	4.24	38.89
Short Term Investments	0.82	13.58	37.43	15.93
Cashand Short Term Investments	80.02	49.48	46.59	56.05
Accounts Receivable- Trade Net	19.48	20.60	16.94	14.01
Total Receivables Net	19.72	21.48	17.93	14.58
Total Inventory	8.56	8.43	10.02	8.00
Other Current Assets Total	1.43	1.23	0.81	0.92
Total Current Assets	109.73	81.09	75.90	79.99
Property/ Plant/ Equipment Total- Net	11.21	11.22	11.30	10.45
Intangibles Net	0.39	0.19	0.31	0.48
Long Term Investments	17.48	36.81	43.62	29.36
Note Receivable- Long Term	0.03	0.06	0.13	0.08
Other Long Term Assets Total	26.26	12.45	11.68	0.83
Total Assets	165.10	141.81	142.95	121.18
Accounts Payable	6.26	6.10	7.11	4.59
Accrued Expenses	0.93	0.26	0.26	0.58
Notes Payable/ Short Term Debt	0.00	2.44	5.82	3.71
Current Portof LT Debt/ Capital Leases	0.00	0.49	0.45	0.42
Other Currentliabilities Total	9.19	6.48	7.64	8.69
Total Current Liabilities	16.38	15.76	21.28	17.99
Total Debt	0.00	2.93	6.76	5.07
Deferred Income Tax	0.79	0.72	0.86	0.82
Other Liabilities Total	2.99	2.94	2.94	2.96
Total Liabilities	20.16	19.42	25.57	22.72
Common Stock Total	4.41	4.41	4.59	4.59
Retained Earnings( Accumulated Deficit)	140.53	116.69	111.93	94.32
Total Equity	144.94	122.39	117.38	98.47
Total Liabilities Shareholders' Equity	165.10	141.81	142.95	121.18
Total Common Shares Outstanding	0.44	0.44	0.46	0.46
Tangible Book Valueper Share Common Eq	327.54	276.90	255.10	213.50
Cash	-	3.52	4.91	1.23
Prepaid Expenses	-	0.46	0.55	0.44
Property/ Plant/ Equipment Total- Gross	-	33.20	31.97	30.39
Accumulated Depreciation Total	-	-21.98	-20.66	-19.95
Goodwill Net	-	0.00	0.00	0.00
Capital Lease Obligations	-	0.00	0.49	0.94
Total Long Term Debt	-	0.00	0.49	0.94
Other Equity Total	-	1.29	0.86	-0.44